References
Moellering RC Jr: The place of quinolones in everyday clinical practice. Chemotherapy 1996, 42, Supplement 1: 54–61.
Allan JD Jr, Eliopoulos GM, Moellering RC Jr: Antibiotics: future directions by understanding structure-function relationships. In: Root RK, Trunkey DD, Sande MA: New surgical and medical approaches in infectious diseases. Churchill Livingstone, New York, 1987, p. 263–284.
Neu HC, Chin N: In vitro activity of the new fluoroquinolone CC-99,219. Antimicrobial Agents and Chemotherapy 1994, 38: 2615–2622.
Domagala JM: Structure-activity and structure-side-effect relationships for the quinolone antibacterials. Journal of Antimicrobial Chemotherapy 1994, 33: 685–706.
Fuchs PC, Barry AL, Brown SD, Sewell, DL: In vitro activity and selection of disk content for disk diffusion susceptibility tests with trovafloxacin. European Journal of Clinical Microbiology & Infectious Diseases 1996, 15: 678–682.
Barry AL, Fuchs PC, Thornsberry C, McLaughlin JC, Jenkins SG, Hardy DJ, Allen SD: Methods of measuring susceptibility of anaerobic bacteria to trovafloxacin, including quality control parameters. European Journal of Clinical Microbiology & Infectious Diseases 1996, 15: 676–678.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moellering, R.C. Introduction. Eur. J. Clin. Microbiol. Infect. Dis. 15, 669–670 (1996). https://doi.org/10.1007/BF01691156
Issue Date:
DOI: https://doi.org/10.1007/BF01691156